NCT07941986
Association Between Maternal Intrapartum Pethidine Exposure and Respiratory Depression in Late-Preterm Newborns
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (15)
Show 10 moreShow less
Arms and interventions
160 late-preterm newborns (34+0 to 36+6 weeks of gestation) born to mothers who received intrapartum pethidine (meperidine), administered as part of routine clinical care at a planned dose of 50 mg administered via intramuscular (IM) or intravenous (IV) injection alongside combined spinal-epidural analgesia using bupivacaine and fentanyl, administered via the intrathecal and epidural route according to the institutional anesthesia protocol and individual clinical requirements.
160 late-preterm newborns (34+0 to 36+6 weeks of gestation) born to mothers who received combined spinal-epidural (CSE) analgesia using bupivacaine and fentanyl, administered via the intrathecal and epidural route according to the institutional anesthesia protocol and individual clinical requirements without intrapartum pethidine exposure.
Drugs: pethidine hydrochloride